AZD3974 Clinical Trials (2026): 1 Studies for Healthy Participants
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 AZD3974 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Participants) and 176 total planned enrollment. 1 AZD3974 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07290283 (Oct 2026).
Where to Participate: All AZD3974 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting AZD3974trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Research Site | Glendale91206 | NCT07290283 | Map |
| MD | Research Site | Baltimore21225 | NCT07290283 | Map |
AZD3974 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting AZD3974 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07290283 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants | P1 | Healthy Participants | 176 | Dec 2025 |
All AZD3974 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07290283 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants | P1 | recruiting | 176 | AstraZeneca | Dec 2025 |
AZD3974 clinical trials: frequently asked questions
- How many AZD3974 clinical trials are there?
- 1 AZD3974 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are AZD3974 clinical trials recruiting in 2026?
- Yes — 1 AZD3974 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is AZD3974 being studied for?
- AZD3974 is being studied for Healthy Participants. The trials are grouped by indication on this page.
- What phase is AZD3974 in?
- AZD3974 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors AZD3974 clinical trials?
- The lead sponsor across the most AZD3974 trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AZD3974as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: